MergerLinks Header Logo
Cover Image Robert Phillips
Robert PhillipsGibson Dunn & Crutcher

Robert Phillips

Partner at Gibson Dunn & Crutcher

Lawyer

San Francisco

Deal Bio

Total Deals10
Valued Deals5
Total Value£2,536M
Avg. Deal Size£507M

Sort

United KingdomUnited Kingdom
Telecommunications Equipment
PublicSchemeMboCross BorderPrivate Equity
Laird Performance Materials

target

Laird Performance Materials

Advent International Corporation

bidder

Advent International Corporation

£1,148m

82 dealmakers

United KingdomUnited Kingdom
Banks
PublicSchemeMajorityAcquisition
Aldermore Group

target

Aldermore Group

Firstrand

bidder

Firstrand

£1,080m

31 dealmakers

United KingdomUnited Kingdom
Diversified Industrials
PrivateAcquisitionPrivate Equity
Safetykleen Europe

target

Safetykleen Europe

Apax Partners

bidder

Apax Partners

value n/a

27 dealmakers

Norway
Third Party Logistics (3PL)
PrivatePrivate EquityAcquisitionMajorityPrivate Equity
Solvtrans As

target

Solvtrans As

Antin Infrastructure Partners

bidder

Antin Infrastructure Partners

value n/a

27 dealmakers

United Kingdom
Software
Private EquityPrivateAcquisitionPrivate Equity
The Access Group

target

The Access Group

Hg Capital

bidder

Hg Capital

value n/a

52 dealmakers

United Kingdom
Software
Private EquityAcquisitionPrivateDomesticMajority
Iris Software Group

target

Iris Software Group

Hg Capital

bidder

Hg Capital

value n/a

42 dealmakers

Germany
Software
Cross BorderAcquisitionPrivateMajority
TALENTSPACE

target

TALENTSPACE

HANDSHAKE

bidder

HANDSHAKE

value n/a

3 dealmakers

United States
Biotechnology
AcquisitionMergerMajorityPrivateDomestic
Serina Therapeutics

target

Serina Therapeutics

Agex Therapeutics

bidder

Agex Therapeutics

value n/a

5 dealmakers

United States
Biotechnology
Cross BorderVenture CapitalPrivate EquityMinorityAcquisitionPrivate
Crossbow Therapeutics

target

Crossbow Therapeutics

Mirae Asset Venture Investment

bidder

Mirae Asset Venture Investment

£62m

9 dealmakers

United States
Biotechnology
AcquisitionDomesticPublicMajorityTender OfferPrivate Equity
Theseus Pharmaceuticals

target

Theseus Pharmaceuticals

Concentra Biosciences

bidder

Concentra Biosciences

£148m

2 dealmakers

United States
Biotechnology
PublicAcquisitionDomesticMajority
Kinnate Biopharma

target

Kinnate Biopharma

Xoma Corporation

bidder

Xoma Corporation

£97m

40 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US